I now have comprehensive information. Let me compile a detailed, well-structured answer on hypomagnesaemia as it would appear in Davidson's-style format, using the authoritative sources gathered.
Hypomagnesaemia
Note: Davidson's Principles and Practice of Medicine is not available in this library. The following is a detailed, clinically structured account drawn from Rosen's Emergency Medicine, Brenner & Rector's The Kidney, Mulholland & Greenfield's Surgery, and related authoritative textbooks - the clinical content aligns closely with what Davidson's covers.
Definition and Normal Values
- Normal serum magnesium: 1.5 - 3.0 mEq/L (0.75 - 1.0 mmol/L)
- Hypomagnesaemia is defined as serum Mg < 1.5 mEq/L (< 0.75 mmol/L)
- Symptoms typically appear when levels fall below 1.2 mEq/L
- Severe hypomagnesaemia: < 1.0 mEq/L (< 0.5 mmol/L) - requires IV replacement
Incidence: ~2% in the general population; much higher in ICU patients and hospitalised patients. It is one of the most common yet underdiagnosed electrolyte abnormalities.
Magnesium Physiology - Brief Review
Magnesium is the second most abundant intracellular cation. The adult body contains ~24 g of magnesium, of which only a tiny fraction (~60 mg) is present in plasma.
Magnesium exists in serum in three forms:
- Ionized (free) - biologically active (~55%)
- Protein-bound (~30%)
- Complexed to anions (~15%)
Renal Handling
- 95-97% of filtered magnesium is reabsorbed along the nephron
- Proximal tubule: 5-15% reabsorption
- Thick ascending limb (TAL): 50-70% - passive paracellular pathway (via claudin-16/claudin-19)
- Distal convoluted tubule (DCT): 5-10% - this is the fine-tuning segment via TRPM6 channel (active transcellular)
- In hypomagnesaemia, normal kidneys can reduce urinary excretion to as little as 0.5% of filtered load
Clinical Assessment of Renal Wasting
- Fractional excretion of magnesium (FEMg) normally < 2% in hypomagnesaemia
- FEMg > 4% = renal magnesium wasting
- Formula: FEMg = (urine Mg × serum Cr) / (0.7 × serum Mg × urine Cr) × 100
Causes of Hypomagnesaemia
1. Dietary / Reduced Intake
- Chronic protein-calorie malnutrition
- Prolonged IV fluid replacement without magnesium supplementation
- Starvation, anorexia nervosa
- Foods rich in magnesium: green vegetables, legumes, fruits, shellfish, fresh meat, cocoa
2. Gastrointestinal Losses
- Chronic diarrhoea (most common GI cause)
- Malabsorption syndromes: coeliac sprue, short bowel syndrome
- Inflammatory bowel disease (Crohn's, ulcerative colitis)
- Vomiting
- Pancreatitis
- Nasogastric suction
- Post-operative bowel resection
3. Renal Wasting (most common in hospitalised patients)
Drug-induced:
| Drug | Mechanism |
|---|
| Loop diuretics (furosemide) | Inhibit magnesium reabsorption in TAL |
| Thiazide diuretics | Inhibit reabsorption in DCT |
| Aminoglycosides | Direct tubular toxicity |
| Cisplatin | Tubular damage |
| Amphotericin B | Tubular toxicity |
| Ciclosporin / Tacrolimus | Renal magnesium wasting (common post-transplant) |
| Proton pump inhibitors | Decreased intestinal Mg absorption (long-term use) |
| Digoxin | Promotes renal wasting |
| Pentamidine | Tubular toxicity |
Note: Potassium-sparing diuretics (spironolactone, amiloride) are also magnesium-sparing.
Non-drug renal causes:
- Post-obstructive polyuria
- Recovery from acute tubular necrosis
- Renal tubular acidosis
- Primary hyperaldosteronism (aldosterone increases renal Mg loss)
4. Endocrine / Metabolic
- Diabetes mellitus (osmotic diuresis)
- Diabetic ketoacidosis (DKA)
- Hyperparathyroidism
- Hyperthyroidism
- Hyperaldosteronism
5. Redistribution
- "Hungry bone" syndrome (after parathyroidectomy)
- Refeeding syndrome
- Insulin therapy
- Acute pancreatitis
6. Alcohol Use Disorder
- Reduced dietary intake
- Alcohol's diuretic effect causing renal wasting
- Episodes of pancreatitis and diarrhoea
- This is a very common and often overlooked cause
7. Genetic / Primary Inherited Disorders
| Group | Syndrome |
|---|
| Hypercalciuric hypomagnesaemias | Familial hypomagnesaemia with hypercalciuria and nephrocalcinosis (FHHNC) - mutations in CLDN16 or CLDN19 |
| Gitelman-like | Gitelman syndrome (SLC12A3), Bartter syndrome types 3 & 4, EAST syndrome (KCNJ10), HNF1B nephropathy |
| Mitochondrial | Mitochondrial metabolic syndrome, Kearns-Sayre syndrome |
| Other | Hypomagnesaemia with secondary hypocalcaemia (TRPM6), Autosomal dominant hypomagnesaemia (KCNA1), EGF signalling defects |
Clinical Features
Hypomagnesaemia is often asymptomatic until serum Mg falls below ~0.4 mmol/L (1.2 mEq/L). Symptoms do not always correlate well with serum levels because most magnesium is intracellular.
Neuromuscular (most prominent)
- Muscle cramps and fasciculations
- Tetany - from coexistent hypocalcaemia (Mg deficiency inhibits PTH secretion + causes PTH resistance)
- Trousseau sign - carpal spasm on BP cuff inflation
- Chvostek sign - facial twitch on tapping over facial nerve
- Hyperactive deep tendon reflexes
- Weakness, fatigue
- Seizures (severe cases)
- Ataxia, vertigo
- Dysarthria and dysphagia (oesophageal dysmotility)
- Depression, agitation, confusion
Cardiovascular
- QT interval prolongation (most important ECG change)
- PR interval prolongation
- ST segment depression
- Flattening/widening of T waves
- U waves (often due to coexistent hypokalaemia)
- Decreased deep tendon reflexes (severe)
- Arrhythmias:
- Atrial fibrillation
- Multifocal atrial tachycardia
- Premature ventricular complexes
- Ventricular tachycardia
- Torsades de pointes (characteristic and dangerous)
- Ventricular fibrillation
- Decreased vascular tone
- Impaired cardiac contractility
Metabolic Consequences
Hypomagnesaemia creates a "metabolic cascade":
- Hypokalaemia - Mg is needed for Na+/K+-ATPase function; ~50% of hypokalaemic patients are also hypomagnesaemic; hypokalaemia refractory to K+ replacement should prompt Mg check
- Hypocalcaemia - Mg deficiency inhibits PTH secretion AND causes PTH resistance in target tissues
- These electrolyte abnormalities worsen each other and must all be corrected together
Investigation / Diagnosis
- Serum magnesium - routine measurement; note: serum level may be normal despite total body deficit because Mg is released from bone
- Urine magnesium or FEMg - to distinguish renal vs. non-renal losses:
- FEMg < 2%: extra-renal cause (GI losses, poor intake)
- FEMg > 4%: renal wasting
- Serum calcium - check for coexistent hypocalcaemia
- Serum potassium - check for coexistent hypokalaemia
- ECG - QT prolongation, arrhythmias
- Assess for underlying cause (medications, alcohol history, GI disease, renal function)
Management
1. Mild / Asymptomatic Hypomagnesaemia (Mg > 1.0 mEq/L)
- Oral magnesium supplementation
- Magnesium oxide 400 mg twice daily
- Alternatives: magnesium chloride, magnesium gluconate, magnesium hydroxide (milk of magnesia)
- Note: oral absorption is variable; doses > 80 mEq/day may cause catharsis
- Address underlying cause
2. Moderate Hypomagnesaemia (Mg 0.5-1.0 mEq/L) - Symptomatic
- IV magnesium sulfate
- Loading dose: 1-2 g IV over 10-60 minutes
- Maintenance: 0.5-1 g/hr until symptoms resolve
- 1 g IV magnesium raises serum Mg by ~0.15 mEq/L within 18-30 hours
- Normal renal function required for safe infusion
3. Severe / Life-threatening (Mg < 1.0 mEq/L, haemodynamic instability, or cardiac arrest)
- IV magnesium sulfate bolus - 1-2 g IV push or over 5 minutes
- For Torsades de Pointes: 2 g IV over 5 minutes
- For cardiac arrest: 1-2 g magnesium sulfate IV push
- Maximum safe infusion rate (non-emergency): 150 mg/min
4. Special Considerations
- Magnesium replacement should accompany potassium replacement in hypokalaemia
- In post-transplant patients with severe hypomagnesaemia (<1.0 mg/dL), IV Mg is especially important in those with CAD, arrhythmias, or on digoxin
- Renal impairment: reduce dose and infusion rate; monitor for hypermagnesaemia
- Monitor for adverse effects of rapid IV replacement: decreased deep tendon reflexes, respiratory depression, heart block
5. Monitoring After Replacement
- Serum Mg often falls again after IV replacement because renal excretion increases
- Ongoing supplementation (oral or IV as appropriate) is needed
- Correct any coexisting hypokalaemia and hypocalcaemia simultaneously
Disposition
| Clinical Status | Action |
|---|
| Cardiac arrhythmias | Admit - telemetry/ICU + cardiology input |
| Symptomatic (tetany, seizures) | Admit - monitored bed, parenteral Mg |
| Asymptomatic, mild | Oral supplements + close outpatient follow-up |
| At discharge | Encourage dietary magnesium; lifestyle changes (weight, BP control) |
Key Clinical Pearls
- Always check Mg in refractory hypokalaemia - replacing K without fixing Mg will fail
- Hypomagnesaemia and hypocalcaemia often coexist - if tetany doesn't respond to calcium, consider hypomagnesaemia
- Torsades de pointes - IV magnesium is first-line treatment regardless of serum Mg level
- Loop and thiazide diuretics are the most common drug causes in outpatients
- Alcohol use disorder is an extremely common and underrecognised cause
- PPIs - long-term use, especially with diuretics, can cause significant hypomagnesaemia
- Serum Mg can be normal despite total body deficit - clinical suspicion in high-risk patients is essential
- Post-transplant patients on calcineurin inhibitors (ciclosporin, tacrolimus) are a very high-risk group
Sources: Rosen's Emergency Medicine (9780323757898), Brenner & Rector's The Kidney (9780323532655), Mulholland & Greenfield's Surgery 7e (9781975143169), Comprehensive Clinical Nephrology 7e (9780323825924)